Skip to main content
Carmen Allegra, MD, Oncology, Gainesville, FL

CarmenJosephAllegraMD

Oncology Gainesville, FL

Physician

Dr. Allegra is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Allegra's full profile

Already have an account?

  • Office

    1600 Sw Archer Rd
    Gainesville, FL 32610
    Phone+1 352-265-0111
    Fax+1 352-273-6867

Education & Training

  • National Institutes of Health Clinical Center
    National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1986 - 1987
  • National Institutes of Health Clinical Center
    National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1982 - 1985
  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemResidency, Internal Medicine, 1979 - 1982
  • Perelman School of Medicine at the University of Pennsylvania
    Perelman School of Medicine at the University of PennsylvaniaClass of 1979

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2007 - 2025
  • PA State Medical License
    PA State Medical License 1981 - 2008
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
  • Elected Member The American Society for Clinical Investigation, 1991

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Tucatinib and Trastuzumab Combination Approved for Advanced Colorectal Cancer
    Tucatinib and Trastuzumab Combination Approved for Advanced Colorectal CancerFebruary 10th, 2023
  • Nivolumab Improves Survival for Some Patients with Advanced Stomach Cancer
    Nivolumab Improves Survival for Some Patients with Advanced Stomach CancerOctober 20th, 2020
  • Liraglutide Gets FDA Indication for Reducing CVD Risk, but Not so Fast
    Liraglutide Gets FDA Indication for Reducing CVD Risk, but Not so FastJune 24th, 2017
  • Join now to see all